The World Health Organization 2016 classification of testicular non‐germ cell tumours: a review and update from the International Society of Urological Pathology Testis Consultation Panel
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The World Health Organization (WHO) released a new tumour classification for the genitourinary system in early 2016 after consensus by pathologists with expertise in these organs. It utilized the framework of the 2004 classification, and incorporated the most up‐to‐date information concerning these tumours. In testicular tumours, the majority of the changes occurred in the nomenclature and classification of germ cell tumours; however, several modifications were also made for non‐germ cell tumours. Among sex cord–stromal tumours, sclerosing Sertoli cell tumour (SCT) is no longer recognized as a separate entity but as a morphological variant of SCT not otherwise specified (NOS), as CTNNB 1 gene mutations have been noted in both neoplasms but not in the other forms of SCT. Similarly, the lipid cell variant is not separately classified, but is considered to be a morphological variant of SCT NOS. Large‐cell calcifying SCT is recognized as a distinct entity that occurs either sporadically or in association with Carney complex, with the latter patients having a distinct germline PRKAR 1A gene mutation. Intratubular large‐cell hyalinizing Sertoli cell neoplasia is also accepted as a separate entity linked with Peutz–Jeghers syndrome. The subcategories of ‘mixed’ and ‘incompletely differentiated’ forms of sex cord/gonadal stromal tumours have been replaced by ‘mixed and unclassified sex cord–stromal tumours’. New entities introduced in the latest WHO revision include: myoid gonadal stromal tumour and ‘undifferentiated gonadal tissue’, a putative precursor lesion of gonadoblastoma, whereas juvenile xanthogranuloma and haemangioma are included in the miscellaneous category of tumours.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aycan, Z., Bas, V. N., Cetinkaya, S., Yilmaz Agladioglu, S., & Tiryaki, T. (2013) · Clinical Endocrinology · doi:10.1111/cen.12033 · Cited by 98 · cited 1×
“cytoplasmic lipofuscin pigment, spotty cytologic atypia, a hormonal profile with high 17hydroxyprogesterone and adrenal androgens, and frequent regression after medical therapy.(12-15) Immunohiostochemical findings are also useful in that the TTAGS does not express androgen”
Reisch, N., Rottenkolber, M., Greifenstein, A., Krone, N., Schmidt, H., Reincke, M., Schwarz, H.-P., & Beuschlein, F. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3181 · Cited by 82
Cited by
Paner, G. P., Stadler, W. M., Hansel, D. E., Montironi, R., Lin, D. W., & Amin, M. B. (2018) · European Urology · doi:10.1016/j.eururo.2017.12.018 · Cited by 621
Self-citation
Metadata
- Authors
- Idrees, M. T., Ulbright, T. M., Oliva, E., Young, R. H., Montironi, R., Egevad, L., Berney, D., Srigley, J. R., Epstein, J. I., Tickoo, S. K., & the Members of the International Society of Urological Pathology Testicular Tumour Panel
- Venue
- Histopathology
- Publisher
- Wiley
- Published
- 2016-12-23
- Volume
- 70
- Issue
- 4
- Pages
- 513-521
- ISSN
- 0309-0167 (ISSN-L)
- 1365-2559
- OpenAlex
- W2533324512
- Cited by
- 234
- References
- 2
- FWCI
- 23.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The World Health Organization 2016 classification of testicular non‐germ cell tumours: a review and update from the International Society of Urological Pathology Testis Consultation Panel. https://app.cochat.ai/papers/10.1111/his.13115
- The paper
- Idrees, M. T., Ulbright, T. M., Oliva, E., Young, R. H., Montironi, R., Egevad, L., Berney, D., Srigley, J. R., Epstein, J. I., Tickoo, S. K., & the Members of the International Society of Urological Pathology Testicular Tumour Panel. (2017). The World Health Organization 2016 classification of testicular non‐germ cell tumours: a review and update from the International Society of Urological Pathology Testis Consultation Panel. Histopathology. https://doi.org/10.1111/his.13115
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.